ABOUT THIS DESK
What AMW Peptides Is
An independent literature digest — not a store, not a clinic, not a consultancy.
What this desk is
AMW Peptides is an independent editorial desk. It covers three research peptides — sermorelin, CJC-1295, and tesamorelin — that sit in the category researchers call growth hormone-releasing hormone analogs. These compounds have attracted substantial scientific and public interest because they act upstream on the pituitary's own GH machinery rather than supplying exogenous growth hormone directly. That premise is genuinely interesting. The evidence behind it is uneven, and part of this desk's job is to say so plainly.
This site is not a store. It sells nothing. It has no commercial relationship with any peptide manufacturer, compounding pharmacy, clinic, or supplement brand. It does not accept sponsored content or affiliate arrangements.
This site is not a clinic or a medical practice. It does not offer consultations, prescriptions, or individualized health guidance. There is no practitioner here. No content on this site should be interpreted as medical advice.
What this desk does: it reads the published literature, summarizes it with citations, names the gaps, and distinguishes between controlled-trial findings and community-reported anecdote. The goal is a quiet, accurate map of what the science shows, for anyone who wants to understand it.
Editorial method
Literature for this desk is selected by following the citations that matter: primary clinical trials, peer-reviewed pharmacology reviews, regulatory agency briefings, and government health databases (PubMed, ClinicalTrials.gov, NIH LiverTox). Each piece of evidence is cited by reference number; the full bibliography is on the references page.
Claims are attributed to their source and species. A finding in rats is reported as a finding in rats. A finding in a 52-week RCT in HIV-positive adults on antiretroviral therapy is reported with those qualifiers intact — not generalized to all adults or all GH-axis questions. Where a finding is from an editorial opinion rather than a clinical trial, we say so. Where community-reported effects come from user forums and wellness-clinic write-ups rather than controlled data, they are labeled explicitly as anecdotal.
When the evidence is insufficient to support a claim, we say the evidence is insufficient. That is not a hedge — it is the finding. One of the main things a literature desk can do is prevent the gap between mechanism and clinical proof from being quietly closed in prose.
Content is reviewed for accuracy against the primary sources cited. No AI-generated citations are used; every reference in the bibliography is a real published source. If you find an error or a broken link, use the contact page to flag it.
Independence and disclaimer
AMW Peptides is independently operated and editorially independent. No content here is written to promote, market, or sell any compound, product, or service.
Research peptides — including the three covered on this desk — are not approved medicines for general use (with the specific exception of tesamorelin's narrow HIV-lipodystrophy indication). They are sold by research suppliers for laboratory research use. Content on this site describes what published research has found; it does not constitute a recommendation to use, acquire, or administer any compound.
Growth hormone-releasing hormone analogs are prohibited in competitive sport under the World Anti-Doping Agency Prohibited List. Athletes subject to anti-doping rules should be aware of this.
For any health decision, consult a qualified medical professional.